Home » Topics » Conferences

Conferences
RSS

In vivo profile of AMD-473

May 14, 1997

IL-18 evaluated for biological and antitumor activity

May 13, 1997

Preliminary phase I results for dolastatin 10 in advanced solid tumors

May 13, 1997

Animal and human pharmacokinetics of 9-NC reported

May 13, 1997

Oral toxicity of SarCNU in rats

May 13, 1997

Preclinical and preliminary clinical studies on flavopiridol

May 13, 1997

Preclinical characterization of aplidine

May 13, 1997

Prevention of breast cancer with Targretin

May 13, 1997

Menarini prepares new NNRTIs with potent anti-HIV activity

May 13, 1997

Orally active FdUrd derivative prepared at Taiho

May 13, 1997

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...